Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02708836 · ClinicalTrials.gov registry record · NA

Limiting Emergence Phenomena After General Anesthesia With Combined LMA and ETT Airway Management Technique

A NA study of Limit Emergence Phenomena After General Anesthesia, sponsored by Milton S. Hershey Medical Center.

Recruiting
Registry status
NA
Development phase
130
Enrollment target
1
Study location

NCT02708836: Recruiting NA study of Limit Emergence Phenomena After General Anesthesia, sponsored by Milton S. Hershey Medical Center.

NCT02708836 is a NA study of Limit Emergence Phenomena After General Anesthesia that is actively recruiting participants, run by Milton S. Hershey Medical Center. The registered enrollment target is 130 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02708836, a NA study of Limit Emergence Phenomena After General Anesthesia, is actively recruiting participants, sponsored by Milton S. Hershey Medical Center.

RECRUITING
Registry status
NA
Development phase
130 participants
Enrollment target
1
Study location

Study Summary

Emergence from general anesthesia with a laryngeal mask airway compared with an endotracheal tube has been shown to favorable with respect to limiting emergence phenomena such as coughing, straining, restlessness, and sympathetic stimulation leading to hypertension and tachycardia. Many anesthesiologists would prefer the use of an ETT to an LMA in cases in which higher ventilation pressures may be required, in those patients who are perceived to be high risk for reflux and pulmonary aspiration of gastric contents, as well as during cases that allow the anesthesiologist to have little accessibility the airway. The aim of this study is to investigate an airway management technique that would allow for the benefits of the ETT in terms of a secure airway for the duration of the surgical procedure as well the potential for less emergence phenomena seen when emerging with an LMA.

Primary Outcome

Difference in heart rate multiplied by systolic blood pressure measured during the \~5 minutes prior to emergence and the \~5 minutes after removal of the airway device. Heart rate is continuously monitored and recorded at one minute intervals. Blood pressure is intermittently monitored at 3 minute intervals. The two SBPs measured prior to removal of the airway device will be multiplied by the HR at those times and the RPPs will be averaged. This will be compared with average of the product of t

Interventions

  • PROCEDURE Induction of anesthesia
  • DEVICE Placement of LMA [Ambu (R) AuraGain (TM) disposable laryngeal mask]
  • DEVICE Laryngoscopy and placement of ETT
  • PROCEDURE Ventilation via the ETT
  • PROCEDURE Removal of the ETT

Study Locations (1)

Pennsylvania

  • Penn State Health - Hershey Medical Center - Hershey

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2020-01-01
Est. Completion 2026-06-01
Phase NA
Milton S. Hershey Medical Center

396 total trials

What NCT02708836 shows while recruiting

NCT02708836 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Limit Emergence Phenomena After General Anesthesia appearing as the primary indexed condition, and to 5 interventions - of which Induction of anesthesia is the first listed.

NCT02708836 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02708836 about?

NCT02708836 is a clinical study titled "Limiting Emergence Phenomena After General Anesthesia With Combined LMA and ETT Airway Management Technique". Emergence from general anesthesia with a laryngeal mask airway compared with an endotracheal tube has been shown to favorable with respect to limiting emergence phenomena such as coughing, straining, restlessness, and sympathetic stimulation leading to hypertension and tachycardia. Many anesthesiol...

What is the current status of trial NCT02708836?

This trial is currently recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2020-01-01. Estimated completion is 2026-06-01.

What conditions does trial NCT02708836 study?

This clinical trial studies the following conditions: Limit Emergence Phenomena After General Anesthesia.

What interventions are being tested in trial NCT02708836?

The interventions under investigation include: Induction of anesthesia (PROCEDURE), Placement of LMA [Ambu (R) AuraGain (TM) disposable laryngeal mask] (DEVICE), Laryngoscopy and placement of ETT (DEVICE), Ventilation via the ETT (PROCEDURE), Removal of the ETT (PROCEDURE).

Who is sponsoring clinical trial NCT02708836?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02708836 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT02708836's enrollment target sits among peer trials

130 733rd of 2000 higher than 1,257 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01492036 · 130 participants

    Long-Term Follow-Up of Recipient of Gene Transfer Research

  • NCT01631617 · 130 participants · Phase 2

    Effects of Treatments on Atopic Dermatitis

  • NCT02368041 · 130 participants

    Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure

  • NCT02604277 · 130 participants · NA

    Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02708836, the US trial registry maintained by the National Library of Medicine. NCT02708836 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.